Treatment refractory Schizophrenia : A Clinical Conundrum
Treatment refractory Schizophrenia : A Clinical Conundrum
edited by Peter F. Buckley, Fiona Gaughran.
- Berlin, Heidelberg Springer International Publishing 2014
- 1 recurso en línea (VIII, 230 p.) 7 ilustraciones, 6 ilustraciones en color
Definitions and scope of treatment-refractory schizophrenia -- Biology of schizophrenia: Is treatment-refractoriness synonymous with severity of illness -- Evolution of refractoriness -- Medical and psychiatric comorbidities:Âmplicating treatment expectations -- Overview of pharmacologic treatments and guidelines -- Clozapine:Âld standard treatment for refractory schizophrenia: Now or never -- Augmenting clozapine and other antipsychotic medications:Ârmacologic choices and differential outcomes -- Augmenting clozapine therapy:Âerging neuromodulatory strategies -- Cognitive remediation for refractory schizophrenia -- Psychological and familial therapies for refractory schizophrenia -- Vocational performance of patients with chronic schizophrenia -- Refractory schizophrenia and the criminal justice system:Âfailure of continuity of care and a real challenge -- Personalized medicine:Ââ€g̃ame changer†the care of patients with treatment-refractory schizophrenia?
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant populationÂremains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. Â this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused Âk is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
9783642452574
10.1007/978-3-642-45257-4 doi
Esquizofrenia
RC514 / .T743 2014
Definitions and scope of treatment-refractory schizophrenia -- Biology of schizophrenia: Is treatment-refractoriness synonymous with severity of illness -- Evolution of refractoriness -- Medical and psychiatric comorbidities:Âmplicating treatment expectations -- Overview of pharmacologic treatments and guidelines -- Clozapine:Âld standard treatment for refractory schizophrenia: Now or never -- Augmenting clozapine and other antipsychotic medications:Ârmacologic choices and differential outcomes -- Augmenting clozapine therapy:Âerging neuromodulatory strategies -- Cognitive remediation for refractory schizophrenia -- Psychological and familial therapies for refractory schizophrenia -- Vocational performance of patients with chronic schizophrenia -- Refractory schizophrenia and the criminal justice system:Âfailure of continuity of care and a real challenge -- Personalized medicine:Ââ€g̃ame changer†the care of patients with treatment-refractory schizophrenia?
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant populationÂremains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. Â this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused Âk is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
9783642452574
10.1007/978-3-642-45257-4 doi
Esquizofrenia
RC514 / .T743 2014